The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement
Abstract Background It is now 25 years since the adoption of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the same concerns raised during its negotiations such as high prices of medicines, market exclusivity and delayed market entry for generics remain relevant...
Saved in:
Main Authors: | Marion Motari (Author), Jean-Baptiste Nikiema (Author), Ossy M. J. Kasilo (Author), Stanislav Kniazkov (Author), Andre Loua (Author), Aissatou Sougou (Author), Prosper Tumusiime (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
by: Stanislav Kniazkov, et al.
Published: (2020) -
A rapid assessment of the National Regulatory Systems for medical products in the Southern African Development Community
by: S. Dube-Mwedzi, et al.
Published: (2020) -
The TRIPS Agreement Implementation in Brazil Patents in the Pharmaceutical Area
by: Mitsuuchi Kunisawa, Viviane Yumy
Published: (2015) -
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
by: Maria Auxiliadora Oliveira, et al. -
Is the right to health undermined by the agreement of trade-related aspects of intellectual property rights? / Helmi Khair
by: Khair, Helmi
Published: (2016)